Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancerKamila Kaminska, Gabriella Honeth|Breast Cancer Research|2021Cited by 40
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leadsKamila Kaminska, Eng‐Hui Chew|Oncotarget|2016Cited by 27